Biomerica, Inc.
Cash Flow Statement
| Line Item | May 2026 | Feb 2026 | Nov 2025 | Aug 2025 | May 2025 | Feb 2025 | Nov 2024 | Aug 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-1.1M | $-1.3M | $-1.3M | $2.0K | $-1.5M | $-1.2M | $-950.0K | $-1.3M |
| Depreciation & Amortization | $17.0K | $20.0K | $20.0K | $20.0K | $23.0K | $21.0K | $22.0K | $21.0K |
| Depreciation | — | — | — | — | — | — | — | — |
| Amortization | $4.0K | $6.0K | $5.0K | $5.0K | $8.0K | $5.0K | $4.0K | $4.0K |
| Stock-Based Compensation | $91.0K | $135.0K | $117.0K | $133.0K | $108.0K | $120.0K | $155.0K | $77.0K |
| Net Cash from Operating Activities | $-912.0K | $-1.3M | $-991.0K | $-268.0K | $-662.0K | $-1.0M | $-791.0K | $-1.3M |
| Investing Activities | ||||||||
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | — | — | — | — | — | — | — | — |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $871.0K | $61.0K | $482.0K | $920.0K | — | — | — | — |
| Net Change in Cash | $-28.0K | $-1.2M | $-510.0K | $654.0K | $-659.0K | $686.0K | $-448.0K | $-1.4M |
| Free Cash Flow | — | — | — | — | — | — | — | — |